Yanli Zhang

Department of Pediatrics, Sichuan University

Affiliated withSichuan University Ministry of Education Chinese Academy of Medical Sciences and Peking Union Medical College

Research Area

Medicine

Biography

Yanli Zhang has not added Biography.
If you are Yanli Zhang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2025
Publication title	2026

Other Publications

Article	Year
[Effect of propofol on spinal excitatory amino acid accumulation]. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery\| PubMed ID: 19594022	2009
[Application of Rogerson spatial pattern surveillance in monitoring infectious diseases: parameter setting and choice of scales of analysis]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition\| PubMed ID: 21866646	2011
Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2. Neurobiology of aging\| PubMed ID: 25189117	2015
FAT10 Is Critical in Influenza A Virus Replication by Inhibiting Type I IFN. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27354218	2016
Total Syntheses of (+)-Gabosine P, (+)-Gabosine Q, (+)-Gabosine E, (-)-Gabosine G, (-)-Gabosine I, (-)-Gabosine K, (+)-Streptol, and (-)-Uvamalol A by a Diversity-Oriented Approach Featuring... The Journal of organic chemistry\| PubMed ID: 28276688	2017
Stereoselective Synthesis of (+)-Annuionone A and (-)-Annuionone B. Journal of natural products\| PubMed ID: 28338330	2017
Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7. Science China. Life sciences\| PubMed ID: 28378154	2019
[Effect of imatinib on the height of children with chronic myeloid leukemia in the chronic phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 32810960	2020
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 32928796	2021
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services. Frontiers in psychiatry\| PubMed ID: 34168583	2021
Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China. Chinese medical journal\| PubMed ID: 34966029	2022
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 t... Journal of hematology & oncology\| PubMed ID: 35982483	2022
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter... Journal of hematology & oncology\| PubMed ID: 36316695	2022
Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity. Journal of cardiovascular development and disease\| PubMed ID: 36354771	2022
Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction. ESC heart failure\| PubMed ID: 36519802	2023
Stage-specific requirement for METTL3-dependent mA modification during dental pulp stem cell differentiation. Journal of translational medicine\| PubMed ID: 36527141	2022
Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction. Journal of the American Heart Association\| PubMed ID: 36645090	2023
[Observational study of chronic myeloid leukemia Chinese patients who discontinued tyrosine kinase inhibitors in the real-world]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 36709147	2022
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter... Journal of hematology & oncology\| PubMed ID: 36803531	2023
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. American journal of hematology\| PubMed ID: 37128776	2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia. Cancer medicine\| PubMed ID: 37409506	2023
Effect of sodium-glucose cotransporter 2 inhibitors on left atrial remodeling and prognosis in patients with type 2 diabetes and heart failure with reduced ejection fraction. Journal of cardiovascular medicine (Hagerstown, Md.)\| PubMed ID: 37642649	2023
Effects of Rhythm Control for Atrial Fibrillation on Cardiac Remodeling and Valvular Regurgitation in Patients with Heart Failure. Cardiovascular drugs and therapy\| PubMed ID: 37646906	2023
Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction. Frontiers in cardiovascular medicine\| PubMed ID: 37817865	2023
Trajectory change of left ventricular ejection fraction after rhythm control for atrial fibrillation in heart failure. ESC heart failure\| PubMed ID: 38097279	2023
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Stu... Clinical lymphoma, myeloma & leukemia\| PubMed ID: 38461040	2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia. Haematologica\| PubMed ID: 38934064	2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy. Blood\| PubMed ID: 39046786	2024
An 8-Year 5-Month-Old Boy with a Basal Ganglia Lesion with Triphasic Waves on Electroencephalogram. Actas espanolas de psiquiatria\| PubMed ID: 39403907	2024
Ythdf2 facilitates precursor miR-378/miR-378-5p maturation to support myogenic differentiation. Cellular and molecular life sciences : CMLS\| PubMed ID: 39503763	2024
Patient-reported outcomes in adults with tyrosine kinase inhibitor-resistant chronic myeloid leukemia receiving olverembatinib therapy. Cancer\| PubMed ID: 39589859	2025
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia. Haematologica\| PubMed ID: 40304058	2025
Case report: A case of acute pancreatitis with myocarditis and thyrotoxicosis. Frontiers in cardiovascular medicine\| PubMed ID: 40662134	2025
Analysis of 47 Non-MHC Ankylosing Spondylitis Susceptibility Loci Regarding Associated Variants across Whites and Han Chinese. The Journal of rheumatology\| PubMed ID: 31523044	2020
Nanochaperones Mediated Delivery of Insulin. Nano letters\| PubMed ID: 32069419	2020
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study. Annals of hematology\| PubMed ID: 34089385	2021
Health-related quality of life in children with chronic myeloid leukemia in the chronic phase. Journal of cancer research and clinical oncology\| PubMed ID: 34714411	2022
Self-Assembled Nanochaperones Inhibit the Aggregation of Human Islet Amyloid Polypeptide Associated with Type 2 Diabetes. ACS macro letters\| PubMed ID: 35549098	2021
A deletion variant within the FGF5 gene in goats is associated with gene expression levels and cashmere growth. Animal genetics\| PubMed ID: 35843706	2022
Validation of the imatinib-therapy failure model. Leukemia\| PubMed ID: 36973351	2023
Chemical constituents from Acorus calamus with potent anti-diabetic and hepatoprotective activities. Fitoterapia\| PubMed ID: 37343685	2023
Analysis of complex chromosomal rearrangement involving chromosome 6 via the integration of optical genomic mapping and molecular cytogenetic methodologies. Journal of human genetics\| PubMed ID: 37821671	2024
Ambient atmospheric PM worsens mouse lung injury induced by influenza A virus through lysosomal dysfunction. Respiratory research\| PubMed ID: 38057804	2023
Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: A systematic review and meta-analysis. Chinese medical journal\| PubMed ID: 38230488	2024
CXCR3-independent role of CXCL10 in alveolar epithelial repair. American journal of physiology. Lung cellular and molecular physiology\| PubMed ID: 38771132	2024
Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study. Frontiers in immunology\| PubMed ID: 39391316	2024
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive. Clinical and molecular hepatology\| PubMed ID: 39736267	2025
Effects of Different Bowel Preparation Regimens and Age Factors on the Gut Microbiota: A Prospective Randomized Controlled Study. Journal of gastroenterology and hepatology\| PubMed ID: 39778910	2025
Lung-specific CRBN knockout attenuates influenza a virus-induced acute lung injury in mice: a potential therapeutic approach. BMC infectious diseases\| PubMed ID: 39833740	2025
Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes. British journal of haematology\| PubMed ID: 40624854	2025
Treatment-free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure. British journal of haematology\| PubMed ID: 40799021	2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation. Haematologica\| PubMed ID: 41098110	2025
[Identify the factors associated with treatment-free remission outcomes after imatinib discontinuation in children and adolescent patients with chronic myeloid leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 41145282	2025